- Earn up to 91.75 AMA PRA Category 1 Credits™ and 30.75 ABIM MOC points
- Gets you ready with a deep QBank of 1200+ practice questions in board format
- Enhances your learning with high-yield online videos presented by board-focused faculty
- Saves time by following the ABIM Medical Oncology board exam topic blueprint
- Fits your busy schedule with anytime, anywhere access
- Includes detailed, illustrated study guide
- Guarantees you′ll pass with The Triple Trust Guarantee
What are the 2023 Medical Oncology Board Pass Rates?
The ABIM 2023 Medical Oncology Pass Rate for the Certification exam is 92%.
The ABIM 2023 Medical Oncology Pass Rate for the Maintenance of Certification exam is 90%.
Why take chances? The Pass Machine Medical Oncology Board Review GUARANTEES you’ll pass!
Nearly 1 in 13 Failed the Oncology CERT
The Medical Oncology Initial Certification Exam is possibly the most challenging of ABIM board exams. Is 2023, 56 out of 702 first-time takers didn’t pass the Oncology Certification exam.
Exam Prep Works
American Board of Internal Medicine recognizes “Exam Prep” as the primary step toward certification. Their Study of Studying infographic reminds us of the acute benefits of using board exam prep as a review and assessment tool.
Pass Guaranteed
The #1 Guarantee in Board Prep for Physicians! The Triple Trust Guarantee from American Physician Institute has your back. As you see from our clients’ board results above, investing in a comprehensive review course pays off.
What do I do if I fail the Oncology board exam?
The first thing you should do is just take it easy, sleep on it. Give yourself a few days, a week or two to come to terms with what has happened. Your next exam is six months to a year away. Dr. Jack has more advice in this video, What Do You Do If You Fail Your Medical Board Exam?
Medical Oncology Certification Exam Scoring
Overall performance is reported on a standardized score scale ranging from 200 to 800, with a mean of 500. To pass the Medical Oncology board examination, your standardized score must equal or exceed the standardized passing score. Your performance on the entire exam determines your pass-fail decision.
The passing standard for the Medical Oncology exam is set by ABIM committee using standard-setting techniques that follow best practices in assessment. Because the passing standard is based on a specified level of mastery of Medical Oncology content, no predetermined percentage of examinees will pass or fail the exam.
Medical Oncology Certification Exam Format
The Medical Oncology Certification Exam (CERT) board exam is composed of up to 240 single-best-answer multiple-choice questions. Most questions describe patient scenarios and ask about the tasks performed by physicians in the course of practice. (Note that around 40 of these are new questions that do not count in your score.)
Example of a single-best-answer multiple-choice question format:
A 70-year-old woman presents with atraumatic ecchymoses around her eyes and mouth. The lesions are waxy and nonpruritic. She is otherwise asymptomatic. Your biopsy reveals positive red deposits with green birefringence under polarized light. Her lab results show abnormal renal function and monoclonal band in urine, a normal platelet count, and 15% plasma cells in her bone marrow. Her skeletal survey is normal. She has increased creatinine. Which one of the following conditions is most likely present in this patient?
◯ A. Acute myeloid leukemia
◯ B. Multiple myeloma with pancytopenia
◯ C. Multiple myeloma with amyloidosis
◯ D. Sarcoidosis
◯ E. Systemic (AA) amyloidosis
Correct Response:
C. Multiple myeloma with amyloidosis
This question refers to multiple myeloma and its corresponding complications. Multiple myeloma with amyloidosis is correct due to the fact that there are typical deposits of amyloid with features of myeloma (plasma cells greater than 10% in bone marrow and a monoclonal band in the urine suggestive of Bence-Jones proteinuria).
Acute myeloid leukemia is incorrect, as there is a plasmacytosis in the bone marrow with no blast cells.
Multiple myeloma with pancytopenia is incorrect, as the platelet counts are normal, which excludes a pancytopenia.
Sarcoidosis is incorrect, as dermatological manifestations of sarcoidosis include lupus pernio, maculopapular, nodular, scar, plaque, angiolupoid, ichthyosiform, lichenoid, psoriasiform, and ulcerative lesions as well as subcutaneous nodules.
Systemic (AA) amyloidosis is incorrect as systemic amyloidosis is a complication of chronic inflammatory diseases; meanwhile, this patient has light-chain amyloidosis.
Source
W. Harris Green. Dermatologic Signs of Multiple Myeloma. N Engl J Med 2011; 365:71. Karen Podlipsky Gould. Dermatologic Manifestations of Sarcoidosis. Available online at: http://emedicine.medscape.com/article/1123970-overview#aw2aab6b3.
Sub-Topic
Medical Oncology